radionuclide therapy Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Jules Bordet Institute (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadmeasurable disease

I am/have/hadrenal function

I am/have/hadbone marrow procedure

I am/have/hadpet/ct scan

I am/have/hadfdg-pet

I am/have/hadrefractory multiple myeloma

I am/have/hadmultiple myeloma

I am/have/hadfdg pet/ct

added new label for I am/have/had

more

I am looking for

I am looking forbortezomib

I am looking forcarfilzomib

I am looking fordaratumumab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients

This study wil assess somatostatin receptor (SSTR) expression via the uptake of Gallium-68 labelled DOTA-conjugated SSTR targeting peptide using PET/CT imaging in multiple myeloma lesions pre-identified on 18F-FDG PET/CT in order to evaluate the feasibility of molecular radionuclide therapy in refractory and relapsing mutiple myeloma using the Lutetium-177 radiolabelled targeting …

bortezomib

measurable disease

renal function

bone marrow procedure

pet/ct scan

0 views
05 Aug, 2020

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.